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Abstract
Despite the current diagnostic and serologic testing for SLE, the interval between the onset
of symptoms and the diagnosis is still long. In this study, we aimed to show the interval between
the initial symptoms and the diagnosis of SLE and to investigate the presence of any relationship
between the interval and the initial symptoms. One hundred and thirty-six patients were diagnosed
with SLE using the 1982 ARA criteria. The mean age of the patients at diagnosis was 29.9 +/-
10.5 years. The mean interval between the onset of symptoms and the diagnosis of SLE was 21.82
+/- 30.32 months. The subjects were evaluated twice, at intervals of < or = 3 and < or = 12
months after the onset of symptoms. Although arthritis and/or arthralgia were the most common
initial symptoms (60.3%), only 26.8% of the patients with these symptoms were diagnosed earlier
than 3 months after the onset. If the first initial symptoms were butterfly rash or pericarditis,
pleuritis, spontaneous abortion or cognitive dysfunction, they led to early diagnosis. In conclusion,
since arthritis and/or arthralgia are the most common initial symptoms of the disease, every young
woman with these symptoms should be carefully evaluated for SLE.
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Despite the current diagnostic and serologic testing for SLE, the interval between the onset of symptoms and the diagnosis is still long. In this study, we aimed to show the interval between the initial symptoms and the diagnosis of SLE and to investigate the presence of any relationship between the interval and the initial symptoms. One hundred and thirty-six patients were diagnosed with SLE using the 1982 ARA criteria. The mean age of the patients at diagnosis was 29.9±10.5 years. The mean interval between the onset of symptoms and the diagnosis of SLE was 21.82±30.32 months. The subjects were evaluated twice, at intervals of  3 and  12 months after the onset of symptoms. Although arthritis and/or arthralgia were the most common initial symptoms(60.3 ),
only 26.8  of the patients with these symptoms were diagnosed earlier than 3 months after the onset. If the ﬁrst initial symptoms were butterﬂy rash or pericarditis, pleuritis, spontaneous abortion or cognitive dysfunction, they led to early diagnosis. In conclusion, since arthritis and/
or arthralgia are the most common initial symptoms of the disease, every young woman with these symptoms should be carefully evaluated for SLE.
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S ystemic lupus erythematosus(SLE)is a multisys-tem disease which primarily aﬀects young females and is caused by tissue damage resulting from antibody and complement-ﬁxing immune complex deposition.
There is a wide spectrum of clinical presentations. The most common initial symptoms of SLE show cutaneous,
musculoskeletal, renal, and hematological involvement.
There is no classical pattern, and the diagnosis should be based on an overall view of the clinical signs and labora-
tory tests［1］. In spite of increased physician awareness and newer diagnostic and serologic testing, the interval between the onset of symptoms and the diagnosis of SLE
 
is still very long［2］. This delay may be due to the characteristics of the ﬁrst symptom(s)and the sex and age of the patients at the onset of the symptoms.
The aim of this study, a follow-up study in 136 adults with SLE in one center, is to investigate the initial symptoms, the interval between the onset of symptoms and the diagnosis of SLE, the causes of the delay in diagnosis, and the prevalence of SLE-related symptoms.
Materials and Methods
 
In this follow up study, we evaluated 136 patients with SLE who were diagnosed at Cukurova University Hospital, in the departments of Rheumatology and Nephrology, between April 1991 and September 2002.
All of the patients fulﬁlled the revised criteria for SLE
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established by the American Rheumatism Association
［3］. All of the patients were Caucasians living in south-
ern Turkey. The detailed medical histories of the patients were obtained, and initial symptoms were determined chronologically from the onset. The study group com-
prised 127 women and 9 men. SLE-related symptoms and laboratory tests including complete blood count,
erythrocyte sedimentation rate, urinary examination,
AST, ALT, total protein, alkaline phosphatase, BUN,
creatinine(Cr), creatinine clearance(C??), Coomb’s test,
ANA, anti-dsDNA, and anti-Sm were evaluated. Pos-
teroanterior chest X-Ray, electrocardiogram and echocar-
diogram were investigated. The time intervals between the initial symptom of the disease and the establishment of a diagnosis were recorded. The word “interval”was accepted to refer to a delay in diagnosis. We also evaluated the association among interval time, character-
ized as  3 months or  12 months, and the initial symptom, and the sex and age of the patient.
We tested diﬀerences between groups deﬁned by the time delay in their diag-
noses using Student’s t or the Mann-Whitney U and Kruskal-Wallis tests, when data were nonparametric. P 0.05 was considered to be signiﬁcant.
Results
 
There were 127 women(93.4 ), and 9 men(6.6 ),
aged 14-60 years. The female-to-male ratio was 14.1:1.
The mean age at diagnosis was 29.9±10.5 years(29.8 for women and 27.8 for men). The most common initial symptoms were arthritis and/or arthralgia in 82(60.3 )
patients, followed by butterﬂy rash in 16(11.8 ), renal involvement in 12 (8.6 ), fever in 5 (3.7 ), throm-
bocytopenia in 5 (3.7 ), anemia in 4 (2.9 ), fatigue,
malaise, and weakness in 3 (2.2 ), photosensitivity reaction in 3(2.2 ), spontaneous abortion in 2(1.5 ),
and cognitive dysfunction, pericarditis, and pleuritis each in 1 (0.8 )(Table 1). The mean interval between the onset of the symptom and the diagnosis of SLE was 21.82±30.32 months. Those patients who had interval times  3 months(n＝41)and 12 months(n＝92)are presented in Table 2 along with their initial symptoms.
We compared the interval times between patients who had arthritis and/or arthralgia, butterﬂy rash or renal involve-
ment as their initial symptom and those who did not. We found that SLE was diagnosed earlier in the patients with butterﬂy rash than in those without butterﬂy rash［the
 
mean interval time 6.56±8.62 months vs. 23.85±31.60 months, respectively, (P＝0.01)］. The diﬀerence in interval times between patients with arthritis and/or arthralgia and those with renal involvement as their initial symptom was not signiﬁcant［23.80±32.66 months vs.
17.92±25.86 months, (P＞0.05), and 22.35±31.27 months vs. 15.10±12.43 months, (P＞0.05), respec-
tively］. The diﬀerence in mean interval time between women and men was not signiﬁcant［21.85±30.67 months vs. 21.33±26.47 months, (P＞0.05)］.
The subjects were divided into 3 groups according to age at onset of the disease, as follows:Group I: 20 years (28 patients);Group II:21-49  years (104 patients);and Group III: 50 years(4 patients). Inter-
val times for each group were 12.64±2.23 months,
31.36±3.14 months, and 54.88±27.44 months, respec-
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Table 1  Initial symptoms at the onset of SLE
 
Manifestations  n＝136 (%)
Arthritis/arthralgia  82  60.3 Butterﬂy rash  16  11.8 Renal involvement  12  8.6 Fever  5  3.7 Thrombocytopenia  5  3.7 Anemia  4  2.9 Fatigue,malaise,weakness  3  2.2 Photosensitivity reaction  3  2.2 Spontaneous abortion  2  1.5 Cognitive dysfunction  2  1.5 Pericarditis  1  0.8 Pleuritis  1  0.8
 
Table 2  Initial symptoms in patients who were diagnosed in  3 and  12 months
 
Manifestations  3 month
［s］
n＝41  
12 month［s］
n＝92
 
Arthritis/arthralgia  22/82  54/82 Butterﬂy rash  8/16  14/16 Renal involvement  2/12  10/12 Fever  0/5  2/5 Thrombocytopenia  3/5  5/5 Anemia  0/4  2/4 Fatigue,malaise,weakness  0/3  0/3 Photosensitivity reaction  0/3  0/3 Spontaneous abortion  1/2  2/2 Cognitive dysfunction  1/2  2/2 Pericarditis  1/1  1/1 Pleuritis  1/1  1/1
2
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 tively. There were signiﬁcant diﬀerences between Group I and Group III and between Group II and Group III
(P＝0.01 for all). There was not any signiﬁcant diﬀerence between Group I and Group II (P＞0.05).
Data are shown in Table 3.
Discussion
 
Systemic lupus erythematosus is a systemic disease,
with the onset of clinical symptoms usually occurring in the patient’s 20s to 30s. Also in our study, the mean age at the diagnosis of SLE was 29.9±10.5 years. In the present study, the most common initial symptoms of SLE were arthritis and/or arthralgia, butterﬂy rash and renal involvement (60.3 , 11.8 , 8.6  respectively).
In similar follow-up studies on SLE, arthritis and/or arthralgia and cutaneous manifestations at the onset of SLE were reported to occur in approximately 80  of patients(60 and 20 , respectively)［4-6］. In another study, it was revealed that skin and mucous membrane involvement(52 ), fever and malaise(48 ), and arthri-
tis and arthralgia (44 )were the major initial clinical manifestations of SLE［7］. Our results were also found to be consistent with the above and several other studies with respect to the frequency of arthritis and/or arthralgia as chief complaints at the onset of SLE［8, 9］.
The mean interval between the onset of symptoms and
 
the diagnosis of SLE was 21.8±30.3 months in our patients. Wallace et al.［10］revealed that the interval between the initial symptoms and diagnosis of SLE patients who were diagnosed between 1950 and 1980 was 4.1 years. Later, the same study group investigated patients with SLE between the years 1980 and 1989 and reported that interval to be 2.1 years［2］. In the Eurolupus cohort study of 1000 patients in 1993, a mean 2-year period between the onset of symptoms and diagno-
sis was documented［11］. Therefore, our ﬁndings are similar to the studies mentioned above. In our study,
30.1  of the patients with SLE were diagnosed earlier than 3 months after the onset of symptoms(Table 2).
Which factors inﬂuence the delay in the SLE diagno-
sis? Arthritis and/or arthralgia are the most common initial symptoms in SLE patients when diagnosed  3 months and 12 months after the onset of symptoms(22 of 41, 54/92, seen in Table 3). However, in patients with arthritis and/or arthralgia, diagnosis of SLE was not earlier than in patients without these symptoms. But,
diagnosis in patients with butterﬂy rash occurs signiﬁcantly earlier than in patients without this symptom.
Although arthritis and/or arthralgia are the most common initial symptoms in several other studies in addition to the present study, only 26.8  of the patients with these symptoms are diagnosed earlier than 3 months after the onset of the symptoms (22/82). The cause of
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Table 3  Delay in diagnosis:The eﬀects of initial symptom, sex and the patient’s age at the onset of diagnosis
 
Initial symptom  Present or not  N  Delay in diagnosis  Comparison  P
 
Arthritis/arthralgia? Yes  82  23.80±32.66  a vs.b ＞0.05 Arthritis/arthralgia? No  54  17.92±25.86 Butterﬂy rash? Yes  16  6.56± 8.62  c vs.d  0.01 Butterﬂy rash? No  120  23.85±31.60 Renal involvement? Yes  10  15.10±12.43  e vs.f ＞0.05 Renal involvement? No  126  22.35±31.27
 
Sex
 
Female? 127  21.85±30.67  g vs.h ＞0.05 Male? 9  21.33±26.47
 
Age at diagnosis
 
20 years? 28  12.64± 2.23  i vs.j ＞0.05 21-49 years? 104  31.36± 3.14  j vs.k  0.019 50 years? 4  54.88±27.44  i vs.k  0.002
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this may be that joint involvement is relatively mild and deformity is rare in SLE. Therefore, patients presenting with symptoms of arthritis and/or arthralgia should be evaluated for SLE carefully, so that SLE can be diagnosed earlier, and morbidity and mortality can be decreased. On the other hand, the patients with initial symptoms of pleuritis, pericarditis, cognitive dysfunction,
spontaneous abortion, and butterﬂy rash are diagnosed earlier because life-threatening organ involvement and its symptoms make patients seek urgent medical help, and butterﬂy rash, a relatively well-known speciﬁc ﬁnding for SLE, is easily noticed by patients and physicians.
Hochberg et al.［12］found that the mean age of onset in men was 40.4 years vs. 31.8 years in women(for our patients, 29.8 in women vs. 27.8 in men). The disease is diﬃcult to diagnose in older patients (over the age of 50). Also, a comparison of the mean delaying time between women and men does not show a signiﬁcant diﬀerence. A shortcoming of our study is that the number of males(9 patients)and patients over 50 years old(4 patients)was not a large enough basis for a meaningful comparison.
However, our ﬁndings are also supported by the other studies showing that SLE is often insidious in patients over the age of 50 years［1, 13］. Catoggio et al.［13］
reported that the duration between symptom onset and diagnosis extended over 48 months in late-onset SLE.
In our study, arthritis and/or arthralgia (86 ),
butterﬂy rash (61 )and anemia(55 )were the most common symptoms. These ﬁndings are similar to the ﬁndings of a number of other studies［2, 3, 5, 14-16］.
Other symptoms that have been found include photosen-
sitivity(48 ), fever(43 ), mouth ulcer(43 ), head-
ache (36 ), fatigue, malaise, weakness (35 ), and alopecia (35 ). The renal involvement in the present study was 28 , which is lower than that found in other studies (36  to 47 )［16, 17］.
In conclusion, butterﬂy rash or life-threatening organ involvement leads to early diagnosis of SLE. Arthritis and/or arthralgia are the most common initial symptoms,
but they are usually associated with a delay in diagnosis,
so every young woman who presents with arthritis and/
or arthralgia should be evaluated for SLE.
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